![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: COX20 |
Gene summary for COX20 |
![]() |
Gene information | Species | Human | Gene symbol | COX20 | Gene ID | 116228 |
Gene name | cytochrome c oxidase assembly factor COX20 | |
Gene Alias | FAM36A | |
Cytomap | 1q44 | |
Gene Type | protein-coding | GO ID | GO:0006996 | UniProtAcc | B3KM21 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
116228 | COX20 | cirrhotic2 | Human | Liver | Cirrhotic | 1.95e-23 | 2.48e-01 | 0.0201 |
116228 | COX20 | cirrhotic3 | Human | Liver | Cirrhotic | 3.79e-16 | 2.17e-01 | 0.0215 |
116228 | COX20 | p6 | Human | Liver | Cyst | 9.39e-03 | -6.10e-01 | -0.0218 |
116228 | COX20 | HCC1 | Human | Liver | HCC | 1.22e-11 | 5.66e+00 | 0.5336 |
116228 | COX20 | HCC2 | Human | Liver | HCC | 1.80e-25 | 5.16e+00 | 0.5341 |
116228 | COX20 | Pt13.a | Human | Liver | HCC | 4.62e-02 | 2.80e-02 | 0.021 |
116228 | COX20 | Pt13.b | Human | Liver | HCC | 1.51e-29 | 5.22e-02 | 0.0251 |
116228 | COX20 | Pt14.a | Human | Liver | HCC | 3.46e-05 | 1.99e-01 | 0.0169 |
116228 | COX20 | Pt14.b | Human | Liver | HCC | 1.95e-12 | 2.24e-01 | 0.018 |
116228 | COX20 | S014 | Human | Liver | HCC | 2.04e-25 | 1.64e+00 | 0.2254 |
116228 | COX20 | S015 | Human | Liver | HCC | 2.69e-23 | 2.02e+00 | 0.2375 |
116228 | COX20 | S016 | Human | Liver | HCC | 2.94e-30 | 1.97e+00 | 0.2243 |
116228 | COX20 | S027 | Human | Liver | HCC | 1.35e-13 | 1.51e+00 | 0.2446 |
116228 | COX20 | S028 | Human | Liver | HCC | 9.18e-15 | 1.30e+00 | 0.2503 |
116228 | COX20 | S029 | Human | Liver | HCC | 1.41e-14 | 1.37e+00 | 0.2581 |
116228 | COX20 | C04 | Human | Oral cavity | OSCC | 6.26e-27 | 1.69e+00 | 0.2633 |
116228 | COX20 | C21 | Human | Oral cavity | OSCC | 1.61e-58 | 2.41e+00 | 0.2678 |
116228 | COX20 | C30 | Human | Oral cavity | OSCC | 3.03e-39 | 2.26e+00 | 0.3055 |
116228 | COX20 | C43 | Human | Oral cavity | OSCC | 1.15e-09 | 3.71e-01 | 0.1704 |
116228 | COX20 | C46 | Human | Oral cavity | OSCC | 4.57e-08 | 3.99e-01 | 0.1673 |
Page: 1 2 3 4 5 6 7 8 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:003310813 | Breast | IDC | mitochondrial respiratory chain complex assembly | 28/1434 | 93/18723 | 1.54e-10 | 1.83e-08 | 28 |
GO:003310823 | Breast | DCIS | mitochondrial respiratory chain complex assembly | 28/1390 | 93/18723 | 7.50e-11 | 9.43e-09 | 28 |
GO:003310820 | Esophagus | HGIN | mitochondrial respiratory chain complex assembly | 47/2587 | 93/18723 | 3.15e-17 | 8.60e-15 | 47 |
GO:00170044 | Esophagus | HGIN | cytochrome complex assembly | 18/2587 | 36/18723 | 2.39e-07 | 1.14e-05 | 18 |
GO:00336173 | Esophagus | HGIN | mitochondrial cytochrome c oxidase assembly | 13/2587 | 22/18723 | 9.51e-07 | 3.80e-05 | 13 |
GO:00085353 | Esophagus | HGIN | respiratory chain complex IV assembly | 14/2587 | 26/18723 | 1.68e-06 | 6.29e-05 | 14 |
GO:0033108110 | Esophagus | ESCC | mitochondrial respiratory chain complex assembly | 83/8552 | 93/18723 | 9.56e-19 | 1.05e-16 | 83 |
GO:001700413 | Esophagus | ESCC | cytochrome complex assembly | 34/8552 | 36/18723 | 5.08e-10 | 1.31e-08 | 34 |
GO:000853512 | Esophagus | ESCC | respiratory chain complex IV assembly | 24/8552 | 26/18723 | 6.87e-07 | 8.99e-06 | 24 |
GO:003361712 | Esophagus | ESCC | mitochondrial cytochrome c oxidase assembly | 21/8552 | 22/18723 | 8.75e-07 | 1.13e-05 | 21 |
GO:00331087 | Liver | Cirrhotic | mitochondrial respiratory chain complex assembly | 64/4634 | 93/18723 | 3.85e-19 | 7.79e-17 | 64 |
GO:0017004 | Liver | Cirrhotic | cytochrome complex assembly | 22/4634 | 36/18723 | 3.92e-06 | 6.70e-05 | 22 |
GO:0033617 | Liver | Cirrhotic | mitochondrial cytochrome c oxidase assembly | 14/4634 | 22/18723 | 1.27e-04 | 1.25e-03 | 14 |
GO:0008535 | Liver | Cirrhotic | respiratory chain complex IV assembly | 15/4634 | 26/18723 | 3.43e-04 | 2.93e-03 | 15 |
GO:003310812 | Liver | HCC | mitochondrial respiratory chain complex assembly | 80/7958 | 93/18723 | 3.47e-18 | 4.15e-16 | 80 |
GO:00170041 | Liver | HCC | cytochrome complex assembly | 30/7958 | 36/18723 | 5.69e-07 | 9.03e-06 | 30 |
GO:00336171 | Liver | HCC | mitochondrial cytochrome c oxidase assembly | 20/7958 | 22/18723 | 3.00e-06 | 3.98e-05 | 20 |
GO:00085351 | Liver | HCC | respiratory chain complex IV assembly | 22/7958 | 26/18723 | 1.23e-05 | 1.39e-04 | 22 |
GO:003310822 | Liver | Cyst | mitochondrial respiratory chain complex assembly | 17/496 | 93/18723 | 3.20e-10 | 6.51e-08 | 17 |
GO:003310818 | Oral cavity | OSCC | mitochondrial respiratory chain complex assembly | 75/7305 | 93/18723 | 2.17e-16 | 1.68e-14 | 75 |
Page: 1 2 3 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0471424 | Breast | IDC | Thermogenesis | 75/867 | 232/8465 | 8.41e-21 | 3.04e-19 | 2.27e-19 | 75 |
hsa0471434 | Breast | IDC | Thermogenesis | 75/867 | 232/8465 | 8.41e-21 | 3.04e-19 | 2.27e-19 | 75 |
hsa0471443 | Breast | DCIS | Thermogenesis | 74/846 | 232/8465 | 8.72e-21 | 3.13e-19 | 2.30e-19 | 74 |
hsa0471453 | Breast | DCIS | Thermogenesis | 74/846 | 232/8465 | 8.72e-21 | 3.13e-19 | 2.30e-19 | 74 |
hsa0471439 | Esophagus | HGIN | Thermogenesis | 91/1383 | 232/8465 | 1.97e-17 | 5.36e-16 | 4.25e-16 | 91 |
hsa04714114 | Esophagus | HGIN | Thermogenesis | 91/1383 | 232/8465 | 1.97e-17 | 5.36e-16 | 4.25e-16 | 91 |
hsa04714211 | Esophagus | ESCC | Thermogenesis | 163/4205 | 232/8465 | 9.22e-11 | 1.14e-09 | 5.86e-10 | 163 |
hsa04714310 | Esophagus | ESCC | Thermogenesis | 163/4205 | 232/8465 | 9.22e-11 | 1.14e-09 | 5.86e-10 | 163 |
hsa0471414 | Liver | Cirrhotic | Thermogenesis | 121/2530 | 232/8465 | 5.70e-13 | 1.36e-11 | 8.36e-12 | 121 |
hsa0471415 | Liver | Cirrhotic | Thermogenesis | 121/2530 | 232/8465 | 5.70e-13 | 1.36e-11 | 8.36e-12 | 121 |
hsa0471422 | Liver | HCC | Thermogenesis | 170/4020 | 232/8465 | 5.36e-16 | 2.25e-14 | 1.25e-14 | 170 |
hsa0471432 | Liver | HCC | Thermogenesis | 170/4020 | 232/8465 | 5.36e-16 | 2.25e-14 | 1.25e-14 | 170 |
hsa0471442 | Liver | Cyst | Thermogenesis | 34/339 | 232/8465 | 3.33e-11 | 8.73e-10 | 7.21e-10 | 34 |
hsa0471452 | Liver | Cyst | Thermogenesis | 34/339 | 232/8465 | 3.33e-11 | 8.73e-10 | 7.21e-10 | 34 |
hsa0471430 | Oral cavity | OSCC | Thermogenesis | 138/3704 | 232/8465 | 7.67e-07 | 4.35e-06 | 2.22e-06 | 138 |
hsa04714113 | Oral cavity | OSCC | Thermogenesis | 138/3704 | 232/8465 | 7.67e-07 | 4.35e-06 | 2.22e-06 | 138 |
hsa04714210 | Oral cavity | LP | Thermogenesis | 105/2418 | 232/8465 | 3.14e-08 | 4.98e-07 | 3.21e-07 | 105 |
hsa0471438 | Oral cavity | LP | Thermogenesis | 105/2418 | 232/8465 | 3.14e-08 | 4.98e-07 | 3.21e-07 | 105 |
hsa0471428 | Prostate | BPH | Thermogenesis | 110/1718 | 232/8465 | 5.16e-21 | 1.42e-19 | 8.78e-20 | 110 |
hsa04714112 | Prostate | BPH | Thermogenesis | 110/1718 | 232/8465 | 5.16e-21 | 1.42e-19 | 8.78e-20 | 110 |
Page: 1 2 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
COX20 | SNV | Missense_Mutation | novel | c.302G>T | p.Arg101Ile | p.R101I | Q5RI15 | protein_coding | deleterious(0) | probably_damaging(0.952) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
COX20 | SNV | Missense_Mutation | novel | c.361N>C | p.Glu121Gln | p.E121Q | Q5RI15 | protein_coding | tolerated(0.07) | possibly_damaging(0.743) | TCGA-BH-A0DZ-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | docetaxel | SD |
COX20 | SNV | Missense_Mutation | novel | c.181T>G | p.Phe61Val | p.F61V | Q5RI15 | protein_coding | deleterious(0) | probably_damaging(0.988) | TCGA-AZ-4315-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
COX20 | SNV | Missense_Mutation | novel | c.197N>T | p.Arg66Ile | p.R66I | Q5RI15 | protein_coding | deleterious(0) | possibly_damaging(0.463) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
COX20 | SNV | Missense_Mutation | novel | c.128N>T | p.Arg43Leu | p.R43L | Q5RI15 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-A5-A2K3-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Chemotherapy | carboplatin | SD |
COX20 | SNV | Missense_Mutation | novel | c.170G>A | p.Gly57Asp | p.G57D | Q5RI15 | protein_coding | deleterious(0) | probably_damaging(0.974) | TCGA-AJ-A3EK-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | carboplatin | CR |
COX20 | SNV | Missense_Mutation | novel | c.318N>C | p.Glu106Asp | p.E106D | Q5RI15 | protein_coding | deleterious(0.03) | benign(0.043) | TCGA-D1-A16X-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
COX20 | SNV | Missense_Mutation | novel | c.13N>G | p.Pro5Ala | p.P5A | Q5RI15 | protein_coding | tolerated_low_confidence(0.14) | benign(0.007) | TCGA-GJ-A3OU-01 | Liver | liver hepatocellular carcinoma | Male | <65 | I/II | Unknown | Unknown | PD |
COX20 | SNV | Missense_Mutation | novel | c.295N>A | p.Gln99Lys | p.Q99K | Q5RI15 | protein_coding | deleterious(0.01) | benign(0.225) | TCGA-53-7626-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Unspecific | Cisplatin | PD |
COX20 | SNV | Missense_Mutation | novel | c.137N>C | p.Ile46Thr | p.I46T | Q5RI15 | protein_coding | tolerated(0.06) | benign(0.013) | TCGA-86-8674-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Chemotherapy | vinblastine | PD |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |